Published in Biochem Med on August 01, 1972
Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia. J Clin Invest (1983) 1.19
Malignant hyperthermia susceptibility: biochemical basis for pathogenesis and diagnosis. Can J Vet Res (1990) 0.88
High skeletal muscle adenylate cyclase in malignant hyperthermia. J Clin Invest (1981) 0.82
Temperature perturbation studies of sarcoplasmic reticulum from malignant hyperthermia pig muscle. J Clin Invest (1979) 0.77
The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum (1987) 9.24
Obesity and knee osteoarthritis. The Framingham Study. Ann Intern Med (1988) 6.36
Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Intern Med (1992) 5.05
Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum (1997) 4.08
The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum (1995) 3.93
Occupational physical demands, knee bending, and knee osteoarthritis: results from the Framingham Study. J Rheumatol (1991) 2.56
Effect of carotid endarterectomy on carotid chemoreceptor and baroreceptor function in man. N Engl J Med (1970) 1.97
Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol (1982) 1.87
The compliance of contracting skeletal muscle. J Physiol (1974) 1.83
Defining radiographic osteoarthritis for the whole knee. Osteoarthritis Cartilage (1997) 1.80
The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study. J Rheumatol (1989) 1.80
Isoflurane: an anesthetic for the eighties? Anesth Analg (1981) 1.42
Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol (1983) 1.36
On the increase in rate of heat production caused by stretch in frog's skeletal muscle. J Physiol (1968) 1.32
Calcium movements in relation to heart function. Basic Res Cardiol (1982) 1.26
Structural and functional changes associated with failure and recovery of hearts after perfusion with Ca2+-free medium. J Mol Cell Cardiol (1975) 1.22
Excitation-contraction coupling in heart. VII. Calcium accumulation in subcellular particles in congestive heart failure. J Clin Invest (1971) 1.22
Does smoking protect against osteoarthritis? Arthritis Rheum (1989) 1.21
Estrogen use and radiographic osteoarthritis of the knee in women. The Framingham Osteoarthritis Study. Arthritis Rheum (1990) 1.21
Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol (1978) 1.21
Cross bridges as the major source of compliance in contracting skeletal muscle. Nature (1975) 1.20
Adenylate cyclase in skeletal muscle. Kinetic properties and hormonal stimulation. J Biol Chem (1972) 1.19
Phosphorylation of cardiac sarcolemma by endogenous and exogenous protein kinases. Arch Biochem Biophys (1979) 1.16
Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol (1983) 1.15
Myocardial cation contents during induction of calcium paradox. Am J Physiol (1979) 1.11
Are risk factors for patellofemoral and tibiofemoral knee osteoarthritis different? J Rheumatol (1996) 1.09
Radiographic hand osteoarthritis: incidence, patterns, and influence of pre-existing disease in a population based sample. J Rheumatol (1997) 1.09
Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol (1999) 1.07
Development of cardiac sensitivity to oxygen deficiency: comparative and ontogenetic aspects. Physiol Rev (1999) 1.07
Habitual physical activity is not associated with knee osteoarthritis: the Framingham Study. J Rheumatol (1993) 1.06
Prostaglandins and heart disease. Can J Cardiol (1985) 1.05
iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. Am J Physiol (1998) 1.05
Calcium binding by skeletal muscle sarcolemma. J Biol Chem (1973) 1.05
Depressed levels of Ca2+-cycling proteins may underlie sarcoplasmic reticulum dysfunction in the diabetic heart. Diabetes (2001) 1.04
Cellular dynamics and lipid metabolism in the lung. Fed Proc (1973) 1.04
Physiological dead space and alveolar-arterial gas pressure differences during exercise. Clin Sci (1966) 1.04
Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy. Circ Res (1986) 1.02
Norepinephrine storage, distribution, and release in diabetic cardiomyopathy. Am J Physiol (1987) 1.02
Agonist-antagonist interactions with rat atrial muscarinic cholinergic receptor sites: differential regulation by guanine nucleotides. Eur J Pharmacol (1979) 1.01
Unusual roentgenologic manifestations of Meckel's diverticulum. Gastrointest Radiol (1981) 1.00
Stimulation of calcium accumulation in cardiac sarcolemma by protein kinase. Can J Biochem (1976) 0.99
Depression of heart sarcolemmal Ca2+-pump activity by oxygen free radicals. Am J Physiol (1989) 0.99
Halothane depresses baroreflex control of heart rate in man. Anesthesiology (1977) 0.99
Sarcoplasmic reticulum Ca(2+)/Calmodulin-dependent protein kinase is altered in heart failure. Circ Res (2000) 0.98
Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol (1985) 0.98
Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate. J Pharmacol Exp Ther (1999) 0.98
Alterations in Ca2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes. Proc Natl Acad Sci U S A (1983) 0.98
Cardiac alpha- and beta-adrenergic receptor alterations in diabetic cardiomyopathy. Basic Res Cardiol (1983) 0.98
Alterations in cardiac membrane Ca2+ transport during oxidative stress. Mol Cell Biochem (1990) 0.97
Correlation between changes in the endogenous energy stores and myocardial function due to hypoxia in the isolated perfused rat heart. Can J Physiol Pharmacol (1972) 0.97
Sarpogrelate inhibits serotonin-induced proliferation of porcine coronary artery smooth muscle cells: implications for long-term graft patency. Ann Thorac Surg (2001) 0.96
Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure. Mol Cell Biochem (2000) 0.96
Sarcoplasmic reticulum Ca(2+)-pump dysfunction in rat cardiomyocytes briefly exposed to hydroxyl radicals. Free Radic Biol Med (1997) 0.95
Induction of necrosis and failure in the isolated perfused rat heart with oxidized isoproterenol. J Mol Cell Cardiol (1975) 0.95
Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J (1992) 0.94
Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy. Am Heart J (1981) 0.94
Guanylate cyclase. Subcellular distribution in cardiac muscle, skeletal muscle, cerebral cortex and liver. Biochem J (1976) 0.94
Cardiac myofibrillar ATPase activity in diabetic rats. J Mol Cell Cardiol (1981) 0.94
Role of extracellular matrix proteins in heart function. Mol Cell Biochem (1993) 0.93
Sarcolemmal Na+-K+-ATPase activity in diabetic rat heart. Am J Physiol (1983) 0.93
Excitation-contraction coupling in heart. 3. Evidence against the involvement of adenosine cyclic 3',5'-monophosphate in calcium transport by sarcotubular vesicles of canine myocardium. Mol Pharmacol (1970) 0.93
Decreased expression of cardiac sarcoplasmic reticulum Ca(2+)-pump ATPase in congestive heart failure due to myocardial infarction. Mol Cell Biochem (1997) 0.93
Sarcolemmal Ca2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats. Am J Physiol (1987) 0.93
Regional and subcellular distribution of myocardial muscarinic cholinergic receptors. Eur J Pharmacol (1978) 0.93
Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine. Am Heart J (2003) 0.92
Alterations in energy metabolism and ultrastructure upon reperfusion of the ischemic myocardium after coronary occlusion. Am J Cardiol (1975) 0.92
Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes (1988) 0.92
Vasopressin (V1) receptor characteristics in rat aortic smooth muscle cells. Am J Physiol (1991) 0.91
Requirement for sulfhydryl groups in the differential effects of magnesium ion and GTP on agonist binding of muscarinic cholinergic receptor sites in rat atrial membrane fraction. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.91
Troponin I phosphorylation in heart homogenate from diabetic rat. Biochim Biophys Acta (1996) 0.91
Myocardial cell damage during experimental infective endocarditis. Lab Invest (1975) 0.91
Excitation-contraction coupling in heart. VI. Demonstration of calcium activated ATPase in the dog heart sarcolemma. Life Sci I (1971) 0.91
Regulatory role of membrane systems in heart function. Can J Physiol Pharmacol (1977) 0.91
Differential changes in left and right ventricular SR calcium transport in congestive heart failure. Am J Physiol (1992) 0.90
Oscillations of intramuscular pH in perfused rat heart. Can J Physiol Pharmacol (1973) 0.90
Alterations in protein kinase A and protein kinase C levels in heart failure due to genetic cardiomyopathy. Can J Cardiol (1999) 0.90
Calcium ion stimulated endogenous protein kinase catalyzed phosphorylation of basic proteins in myelin subfractions and myelin-like membrane fraction from rat brain. Biochemistry (1980) 0.90
Mechanisms of cardiac cell damage due to catecholamines: significance of drugs regulating central sympathetic outflow. J Cardiovasc Pharmacol (1994) 0.89
Regional pulmonary blood flow and gas exchange in hrmorrhagic shock. J Appl Physiol (1968) 0.89
Mechanisms of lysophosphatidylcholine-induced increase in intracellular calcium in rat cardiomyocytes. J Pharmacol Exp Ther (1998) 0.89
Subcellular calcium transport in failing hearts due to calcium deficiency and overload. Am J Physiol (1976) 0.89
Phospholipase D activity in subcellular membranes of rat ventricular myocardium. Biochim Biophys Acta (1991) 0.89
Sarcolemmal Na(+)-K(+)-ATPase activity in congestive heart failure due to myocardial infarction. Am J Physiol (1992) 0.89
Computer assistance in the clinical investigation of pulmonary function studies. Methods Inf Med (1973) 0.88
Characterization of insulin receptors in cardiac sarcolemmal and sarcoplasmic reticular membranes. J Cardiovasc Pharmacol (1987) 0.88
Abnormalities in heart membranes and myofibrils during bacterial infective cardiomyopathy in the rabbit. Circ Res (1976) 0.88
Pseudoarthrosis in ankylosing spondylitis mimicking infectious diskitis: MR appearance. AJNR Am J Neuroradiol (1992) 0.88
Calcium-related changes in the ultrastructure of mammalian myocardium. Br J Exp Pathol (1979) 0.88
Passive and active calcium fluxes across plasma membranes. Prog Biophys Mol Biol (1980) 0.88
Mechanism for depression of heart sarcolemmal Ca2+ pump by oxygen free radicals. Am J Physiol (1989) 0.88
Involvement of membrane systems in heart failure due to intracellular calcium overload and deficiency. J Mol Cell Cardiol (1976) 0.88
Anti-atherosclerotic molecules targeting oxidative stress and inflammation. Curr Pharm Des (2009) 0.88
Role of oxidative stress in catecholamine-induced changes in cardiac sarcolemmal Ca2+ transport. Arch Biochem Biophys (2001) 0.88
Altered responsiveness of guanylyl cyclase to nitric oxide following treatment of cardiomyocytes with S-nitroso-D,L-acetylpenicillamine and sodium nitroprusside. Biochem Biophys Res Commun (1997) 0.88
Role of H2O2 in changing beta-adrenoceptor and adenylyl cyclase in ischemia-reperfused hearts. Mol Cell Biochem (1998) 0.87
The effects of age on baroreceptor reflex function in man. Can Anaesth Soc J (1976) 0.87
Formation of gigantic mitochondria in hypoxic isolated perfused rat hearts. Experientia (1969) 0.87
Metabolic rate, respiratory exchange ratio, and apneas during meditation. Am J Physiol (1989) 0.87